| Nome |
# |
|
A European survey of Non- Invasive Ventilation (NIV), file d9242419-2e58-43ab-a1af-8326a6e86d15
|
56
|
|
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets, file a0fb6907-812e-4daa-bd73-3c70d2ce21d5
|
40
|
|
Impact of chronic obstructive pulmonary disease on passive viscoelastic components of the musculoarticular system, file dfe4d22e-957e-bb0a-e053-d805fe0a78d9
|
18
|
|
Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction, file dfe4d226-f88b-bb0a-e053-d805fe0a78d9
|
17
|
|
Utility of ultrasound assessment of diaphragmatic function before and after pulmonary rehabilitation in COPD patients, file dfe4d22b-a907-bb0a-e053-d805fe0a78d9
|
17
|
|
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report, file 783eb925-f3ab-4e3c-9e17-13022b18d390
|
14
|
|
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps, file 7bd1c8d9-6ea4-4ad3-9019-3fa043df5505
|
12
|
|
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?, file d7678c23-a162-4e74-be41-20fec43ead11
|
12
|
|
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study, file 3957a959-1afd-4edb-b3b8-e0deb12e76b2
|
11
|
|
Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies, file 517b91dc-f98f-4de2-b4be-18d46eb0a7b3
|
11
|
|
Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer, file 826a0703-c02a-42ef-ae7d-ec8cbd67c061
|
11
|
|
Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma, file a2497564-1eca-4857-af69-3ee17288a1b7
|
11
|
|
Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study, file 06e6f689-2e7d-4a89-8ba3-82cc4b6380b9
|
10
|
|
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study, file 0bb3def2-99a1-4197-8c98-665af87b51b8
|
10
|
|
State of the art in interstitial pneumonia with autoimmune features: A systematic review on retrospective studies and suggestions for further advances, file dfe4d22b-7f87-bb0a-e053-d805fe0a78d9
|
10
|
|
Bronchodilator response as a marker of poor asthma control, file dfe4d22c-d63a-bb0a-e053-d805fe0a78d9
|
10
|
|
Effect of high-flow nasal therapy on dyspnea, comfort, and respiratory rate, file baa36dab-dc57-466d-901a-7ac70c5a0b5b
|
9
|
|
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial, file bdf9489c-ace8-4bd0-8779-719e33104506
|
9
|
|
Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells, file df83e2a9-279c-4283-89d9-906475f9f9b3
|
9
|
|
Challenges for the female health-care workers during the COVID-19 pandemic: the need for protection beyond the mask, file fe1ae79b-72b2-4708-93aa-516354a43e17
|
9
|
|
High Level of Blood Eosinophils and Localization of Bronchiectasis in Patients with Severe Asthma: A Pilot Study, file 096fb51c-c83c-4f43-b9dd-48f67963306d
|
8
|
|
Comment on Liu et al. Application of High-Flow Nasal Cannula in COVID-19: A Narrative Review. Life 2022, 12, 1419, file 1b154367-a037-466e-bd34-8e4521a14887
|
8
|
|
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study, file 6483993e-d6e0-4a20-8673-c52aeaa79626
|
8
|
|
No more bullying in medical research, file 866b52d3-20dd-4db6-b7b9-88b4385c96eb
|
8
|
|
Secretion management in patients with ineffective airway clearance with non-invasive mechanical ventilation use: Expert guidance for clinical practice, file 903095f8-e6cc-4f42-bd59-382f814a1d38
|
8
|
|
Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma, file a1522b80-7bd1-4ffa-aa28-6481e221954c
|
8
|
|
Performance of EasyBreath Decathlon Snorkeling mask for delivering continuous positive airway pressure, file c46f227e-7b67-4da3-906a-949ae9e30f11
|
8
|
|
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial, file dc2528b0-8e46-44a1-9aa0-febe6474d033
|
8
|
|
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments, file f0d962fc-ca63-4a43-a284-21e56587bb51
|
8
|
|
REINVENT: ERS International survey on REstrictive thoracic diseases IN long term home noninvasive VENTilation, file 3bc775f1-58c7-445f-beae-8a360c09a6e8
|
7
|
|
Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO), file 4c845694-5a90-486c-9a24-ca2d97c59cc4
|
7
|
|
Novel Biological Therapies for Severe Asthma Endotypes, file 9b005a46-4c6d-4119-b610-a00b073b0c08
|
7
|
|
Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics, file dfe4d22c-cf99-bb0a-e053-d805fe0a78d9
|
7
|
|
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study, file f7255b56-3bd8-492e-896f-41a8513c5460
|
7
|
|
Resumption of respiratory outpatient services in the COVID-19 era: Experience from Southern Italy, file 005c5655-7c3e-42ef-8ca3-70a4ae4ce498
|
6
|
|
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy, file 07789c2c-3636-4a16-bf93-479a28ff4d9a
|
6
|
|
High Flow Nasal Therapy Use in Patients with Acute Exacerbation of COPD and Bronchiectasis: A Feasibility Study, file 1a385ab3-2ddb-433d-bf37-81de6adbf8a3
|
6
|
|
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program, file 392efe86-8732-4b7c-95e0-033c30a00fe9
|
6
|
|
The influence of policies limiting author self-citations on journals impact factor and self-citation rate in respiratory system, file 3dc375b4-3252-4d72-b4a4-bd48ea2b07b2
|
6
|
|
Personalized Medicine in Asthma: Current Approach and Future Perspectives, file 43ce46ca-0764-45cf-bf58-88aa6ed4240d
|
6
|
|
Switching Biological Therapies in Severe Asthma, file 68f7a2bf-8073-4bd0-8f01-da5e3c200e6f
|
6
|
|
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13, file ad009d45-7e9a-4c59-a1af-e8f07f74ca6a
|
6
|
|
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study, file ccbfb0bd-2b43-4147-abf5-036c5a0fe7b1
|
6
|
|
Long-term home noninvasive ventilation (LTHNIV) in restrictive thoracic diseases: The Italian snapshot, file d7e06d67-394e-43b4-93fd-d690adb7528b
|
6
|
|
Is the Power Spectrum of Electromyography Signal a Feasible Tool to Estimate Muscle Fiber Composition in Patients with COPD?, file dfe4d22e-957c-bb0a-e053-d805fe0a78d9
|
6
|
|
A pragmatic, open-label, multi-center, randomized controlled clinical trial on the rotational use of interfaces vs standard of care in patients treated with noninvasive positive pressure ventilation for acute hypercapnic respiratory failure: the ROTAtional-USE of interface STUDY (ROTA-USE STUDY), file e382937d-24cf-4f06-83e6-cba33668146c
|
6
|
|
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study, file 018e4b9b-53a0-4c5e-a50f-a079dded43f1
|
5
|
|
Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis, file 0bc13af2-940f-4083-932d-3b7aeeb80238
|
5
|
|
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis, file 165da415-7fdb-468b-96ec-08c58750026c
|
5
|
|
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis, file 4f582e73-eca6-4d37-beb1-aa08d3e419ce
|
5
|
|
Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma, file 7435cac8-a462-43e1-9c66-6ac5bc7295e9
|
5
|
|
Comparability of asthma control test scores between self and physician-administered test, file 8866c84d-98fb-48c2-8ff0-ec4faefd9491
|
5
|
|
Reliability and usefulness of a rapid IgM‐IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report, file 8b733b29-9e7e-4d88-b697-e1395a51dbeb
|
5
|
|
Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers, file a4fc9724-21dc-4765-aff2-e342ddc2404b
|
5
|
|
Performance of helmet CPAP using different configurations: Turbine-driven ventilators vs Venturi devices, file b63d2c2b-cc09-4a18-917d-b9992e35a780
|
5
|
|
Lessons from COVID-19 in the management of acute respiratory failure, file d3050fee-d495-4643-8a70-95b601a6ab0c
|
5
|
|
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience, file 13baed80-b3ca-4394-9a35-a79350a6f8f5
|
4
|
|
Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey, file 292bbd76-5438-450c-852d-f8b01db35f58
|
4
|
|
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression, file 48be539c-426f-4668-b15b-91ba2b16592f
|
4
|
|
High-Flow Nasal Cannula and COVID-19: A Clinical Review, file 5550ae99-537d-455e-a3a4-f9c505df3f47
|
4
|
|
Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension, file 73938e80-2ba2-4ea3-9462-6604ad46909a
|
4
|
|
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group, file 73c6cdc8-688e-45e9-8410-e45a2a1b86ef
|
4
|
|
A Key to Unlocking the Mysteries of COVID-19 Pulmonary Sequelae: Are We There?, file 8d96eb5a-c2bc-48f6-be8f-538a395b9fbb
|
4
|
|
Why, whether and how to use high-flow nasal therapy in acute exacerbations of chronic obstructive pulmonary disease, file e1e8591c-2446-41aa-b6d4-235f9abbfd8e
|
4
|
|
Adherence to omalizumab: A multicenter "real-world" study, file ffbaedb5-0dd5-4de4-9b97-5284260429b6
|
4
|
|
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma, file 208519ad-faa7-4f5a-ae0d-c8b8601bf0c6
|
3
|
|
Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use, file 2a64d98c-9213-471e-9c7d-b6eda8ca95a0
|
3
|
|
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma, file 2df5474b-804a-4a36-97c8-2a3a7eb1bc00
|
3
|
|
Practical considerations for spirometry during the COVID-19 outbreak: Literature review and insights, file 3a88c2bd-286e-4d95-94bb-1f7606aa225a
|
3
|
|
Home respiratory strategies in COPD patients with chronic hypercapnic respiratory failure: a systematic review and network meta-analysis, file 48a235f8-6638-4054-b43c-b09560df404f
|
3
|
|
High-Flow Nasal Therapy in Acute and Chronic Respiratory Failure: Past, Present, and Future, file 874e585e-4047-4fd8-8044-5ff3150ebd6f
|
3
|
|
Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities, file cf638fba-c6e1-4f25-aeba-ec747b760a7b
|
3
|
|
Molecular Targets for Biological Therapies of Severe Asthma, file e4b5e135-ff6a-4d5a-9dde-503d9e177952
|
3
|
|
Go With the Flow: The Dilemma of Long-Term Oxygen Prescription After Recovery, file f223c3a0-0221-4294-9d48-72981202b0a0
|
3
|
|
A new gambler at the table of management of COVID-19 associated acute respiratory failure. Changing position to do it better?, file 9783b363-c47e-43cb-a771-4535ca3a8239
|
2
|
|
Continuous vs intermittent Non-Invasive blood pressure MONitoring in preventing postoperative organ failure (niMON): study protocol for an open-label, multicenter randomized trial, file dcc3f14c-5728-403d-b7fc-6d548bf17224
|
2
|
|
Prevalence and determinants of co-morbidities in patients with obstructive apnea and chronic obstructive pulmonary disease, file dfe4d22b-a820-bb0a-e053-d805fe0a78d9
|
2
|
|
Exhaled breath condensate pH and cysteinyl leukotriens in patients with chronic cough secondary to acid gastroesophageal reflux, file dfe4d22c-d638-bb0a-e053-d805fe0a78d9
|
2
|
|
Vitamin D and disease
severity in bronchiectasis. Jan 24. PubMed PMID: 30827468., file ea0e0502-73fd-4f52-b29b-6f5a8afd467d
|
2
|
|
Bronchiectasis and asthma: a dangerous liaison?, file 01079c10-bf28-4a7d-9f7c-3618a710798a
|
1
|
|
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report, file 073e54ee-161b-46d1-8cfa-8d39bc136154
|
1
|
|
Tezepelumab for asthma, file 1a6f5c2c-84a7-4ad8-9fb9-c37ddd0bb814
|
1
|
|
Airway hyperresponsiveness with chest strapping: A matter of heterogeneity or reduced lung volume?, file 376d653e-cce0-4942-a4f7-a10ca6bf721c
|
1
|
|
Clinical Recovery Should Be Considered as an Outcome Measure in Clinical Trials Including Patients With New-Onset Hypoxemia, file 44465996-4599-4b41-8241-e3fd1a1f8ff2
|
1
|
|
The Link between Asthma and Bronchiectasis: State of the Art, file 649805cb-0518-4db9-a814-eb7bf22f6702
|
1
|
|
Ultrasound-guided placement of long peripheral cannula in children with cystic fibrosis, file 6eac4349-367a-4bfe-8b60-c37482bb4447
|
1
|
|
High flow nasal therapy in Acute Exacerbation of COPD: Ready for the prime time?, file 7b4f6270-5ed7-46a6-b1db-e8a04aa6d09f
|
1
|
|
Diagnostic delay in bronchiectasis: an Italian perspective, file 91d363cb-6663-4bb5-96d6-3249b7b5f206
|
1
|
|
The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition, file dfe4d22b-9877-bb0a-e053-d805fe0a78d9
|
1
|
|
Point-of-care blood eosinophil count in a severe asthma clinic setting, file dfe4d22c-d6e4-bb0a-e053-d805fe0a78d9
|
1
|
|
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma, file e402a823-4e06-4309-a23f-608813198de5
|
1
|
|
Anti-inflammatory role of vitamin D in muscle dysfunctions of
patients with COPD: a comprehensive review., file e5161b97-6d74-4ef0-b10b-7c11decee279
|
1
|
|
The right interface for the right patient in noninvasive ventilation: a systematic review, file e8093358-95b3-41f6-ac88-3e68a8bd3f06
|
1
|
| Totale |
622 |